Binovi Technologies (Binovi Technologies) EBITDA Margin % : 16,494.74% (As of Feb. 2022)

View and export this data going back to 2012. Start your Free Trial

What is Binovi Technologies EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Binovi Technologies's EBITDA for the three months ended in Feb. 2022 was $-9.40 Mil. Binovi Technologies's Revenue for the three months ended in Feb. 2022 was $-0.06 Mil. Therefore, Binovi Technologies's EBITDA margin for the quarter that ended in Feb. 2022 was 16,494.74%.

Binovi Technologies EBITDA Margin % Historical Data

The historical data trend for Binovi Technologies's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Binovi Technologies EBITDA Margin % Chart

Binovi Technologies Annual Data

Trend

Feb13

Feb14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

EBITDA Margin %

Get a 7-Day Free Trial

-2,560.76

-690.10

-1,071.95

-1,143.46

-8,153.42

Binovi Technologies Quarterly Data
	May17	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22
EBITDA Margin %	Get a 7-Day Free Trial															-1,804.48	-1,276.14	-1,102.67	-1,371.11	16,494.74

Competitive Comparison of Binovi Technologies's EBITDA Margin %

For the Health Information Services subindustry, Binovi Technologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Binovi Technologies's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Binovi Technologies's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Binovi Technologies's EBITDA Margin % falls into.

Binovi Technologies EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Binovi Technologies's EBITDA Margin % for the fiscal year that ended in Feb. 2022 is calculated as

EBITDA Margin %	=	EBITDA (A: Feb. 2022 )	/	Revenue (A: Feb. 2022 )
	=	-11.904	/	0.146
	=	-8,153.42 %

Binovi Technologies's EBITDA Margin % for the quarter that ended in Feb. 2022 is calculated as

EBITDA Margin %	=	EBITDA (Q: Feb. 2022 )	/	Revenue (Q: Feb. 2022 )
	=	-9.402	/	-0.057
	=	16,494.74 %

Binovi Technologies (OTCPK:BNVIF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Binovi Technologies EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Binovi Technologies's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Binovi Technologies (Binovi Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Binovi Technologies Corp (OTCPK:BNVIF) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, Suite 1500, Vancouver, BC, CAN, V6E 4N7

Website

https://www.binovi.com

Binovi Technologies Corp is engaged in the development and commercialization of visual and neuro-cognitive processing products and manufacturing hardware and software for diagnosing and remediating visual perception disorders. The company has three geographical segments; the United States, Canada, and Other. it derives a majority of its revenue from the United States.